Special Drug Use Surveillance of LIXIANA Tablet - Long-term use in patients with non-valvular atrial fibrillation -

Trial Profile

Special Drug Use Surveillance of LIXIANA Tablet - Long-term use in patients with non-valvular atrial fibrillation -

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Apr 2017

At a glance

  • Drugs Edoxaban (Primary)
  • Indications Embolism; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ETNA-AF-Japan
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 16 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top